How one Canadian research center increased their sample size and strengthened insights

CHU Sainte-Justine, a Canadian research center, needed to study medication associations with pregnancy outcomes before, during, and after pregnancy, and used longitudinal MarketScan real-world data (described by Merative as "research grade," "precise and tokenized") to do so. The page states the center achieved an increased sample size and strengthened insights but gives no specific numbers or detailed results; those are only in a downloadable PDF that was not reachable via fetch.

Merative is the former IBM Watson Health, now an independent company behind the MarketScan claims database and the Zelta clinical-trial platform.

This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.